Zymeworks (ZYME) Interest Expenses (2021 - 2026)
Zymeworks (ZYME) reported Interest Expenses of $19.4 million for Q1 2026, up 1750.48% on a YoY basis from $1.0 million in Q1 2025, and up 1712.43% sequentially from $1.1 million in Q4 2025.
Zymeworks (ZYME) Interest Expenses (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Interest Expenses data on file, last reported at $19.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 1750.48% year-over-year to $19.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.4 million (up 402.54% YoY), and the FY2025 full-year result was $274.5 million, up 10.13% from the prior year.
- Interest Expenses grew to $19.4 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $35.3 million in Q3 2022 to a low of $881000.0 in Q2 2024.
- A 5-year average of $12.1 million and a median of $1.3 million in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses slumped 97.23% in 2024 and surged 2321.57% in 2025, its largest moves.
- Tracing ZYME's Interest Expenses over 5 years: stood at $1.1 million in 2022, then rose by 22.67% to $1.4 million in 2023, then decreased by 29.27% to $957000.0 in 2024, then gained by 11.81% to $1.1 million in 2025, then surged by 1712.43% to $19.4 million in 2026.
- Business Quant data shows ZYME's Interest Expenses at $19.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | 19.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.39 Mn |
| Mar 31, 2026 | 19.39 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 21.33 Mn |
| Jun 30, 2025 | 21.33 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 957,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Sep 30, 2024 | 973,000.00 |
| Sep 30, 2024 | 973,000.00 |
| Jun 30, 2024 | 881,000.00 |
| Jun 30, 2024 | 881,000.00 |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2023 | 1.35 Mn |